Publication | Closed Access

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

MedicineGynecologyPrincess MargaretCancer TreatmentOncologyRadiation OncologyRecurrent Endometrial CarcinomaGynecology OncologyCalifornia ConsortiaEndocrine-related Cancer